Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Ramos-Esquivel

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Cancer Treatment and Research Communications|May 4, 2020
Cyclin‑dependent kinase 4/6 inhibitors in combination with fulvestrant for previously treated metastatic hormone receptor‑positive breast cancer patients: A systematic review and meta‑analysis of randomized clinical trialsAllan Ramos-Esquivel, Gabriel Hernández-Romero, Denis Ulises Landaverde
Allergy, Asthma & Immunology Research|September 5, 2013
Vitamin d insufficiency and asthma severity in adults from costa ricaFelicia Montero-Arias, Giovanni Sedó-Mejía, Allan Ramos-Esquivel
Journal of Gastrointestinal Oncology|June 12, 2019
Evaluation of pharmacological therapies used in Costa Rica in patients with metastatic gastric cancer: a retrospective studyEugenia Cordero-García, Allan Ramos-Esquivel, Warner Alpízar-Alpízar
International Journal of Clinical Pharmacy|December 2, 2016
Improvement of time in therapeutic range with warfarin by pharmaceutical interventionAlvaro Víquez-Jaikel, Victoria Hall-Ramírez, Allan Ramos-Esquivel
Journal of Gastrointestinal Oncology|March 23, 2018
Predictors of overall survival after surgery in gastric cancer patients from a Latin-American countryEugenia Cordero-García, Allan Ramos-Esquivel, Warner Alpízar-Alpízar
Anti-Cancer Drugs|November 1, 2025
Low relative dose intensity adjuvant chemotherapy in elderly patients with breast cancer: predictors and impact on survivalAllan Ramos-Esquivel, David Romero-Orocu, Raquel Mora-Hidalgo
Anti-Cancer Drugs|February 2, 2023
A systematic review and meta-analysis on overall survival, failure-free survival and safety outcomes in patients with metastatic hormone-sensitive prostate cancer treated with new anti-androgensAllan Ramos-Esquivel, Esteban Garita-Rojas, Adriana Masis-Marroquín
Pharmacogenetics and Genomics|June 11, 2021
C677T and A1298C MTHFR gene polymorphisms and response to fluoropyrimidine-based chemotherapy in Mestizo patients with metastatic colorectal cancerAllan Ramos-Esquivel, Ricardo Chinchilla-Monge, Jad Abbas, et al.
Journal of Nephropathology|October 5, 2017
Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled studyViviana Navarro-Rodríguez, Alvaro Herrera-Munoz, Adrián Castro, et al.
Journal of Gastrointestinal Cancer|January 3, 2014
Prognosis impact of the lymph node ratio in patients with colon adenocarcinoma: a single-centre experienceAllan Ramos-Esquivel, Melissa Juárez, Ileana González, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Cancer Treatment and Research Communications|May 4, 2020
Cyclin‑dependent kinase 4/6 inhibitors in combination with fulvestrant for previously treated metastatic hormone receptor‑positive breast cancer patients: A systematic review and meta‑analysis of randomized clinical trialsAllan Ramos-Esquivel, Gabriel Hernández-Romero, Denis Ulises Landaverde
Allergy, Asthma & Immunology Research|September 5, 2013
Vitamin d insufficiency and asthma severity in adults from costa ricaFelicia Montero-Arias, Giovanni Sedó-Mejía, Allan Ramos-Esquivel
Journal of Gastrointestinal Oncology|June 12, 2019
Evaluation of pharmacological therapies used in Costa Rica in patients with metastatic gastric cancer: a retrospective studyEugenia Cordero-García, Allan Ramos-Esquivel, Warner Alpízar-Alpízar
International Journal of Clinical Pharmacy|December 2, 2016
Improvement of time in therapeutic range with warfarin by pharmaceutical interventionAlvaro Víquez-Jaikel, Victoria Hall-Ramírez, Allan Ramos-Esquivel
Journal of Gastrointestinal Oncology|March 23, 2018
Predictors of overall survival after surgery in gastric cancer patients from a Latin-American countryEugenia Cordero-García, Allan Ramos-Esquivel, Warner Alpízar-Alpízar
Anti-Cancer Drugs|November 1, 2025
Low relative dose intensity adjuvant chemotherapy in elderly patients with breast cancer: predictors and impact on survivalAllan Ramos-Esquivel, David Romero-Orocu, Raquel Mora-Hidalgo
Anti-Cancer Drugs|February 2, 2023
A systematic review and meta-analysis on overall survival, failure-free survival and safety outcomes in patients with metastatic hormone-sensitive prostate cancer treated with new anti-androgensAllan Ramos-Esquivel, Esteban Garita-Rojas, Adriana Masis-Marroquín
Pharmacogenetics and Genomics|June 11, 2021
C677T and A1298C MTHFR gene polymorphisms and response to fluoropyrimidine-based chemotherapy in Mestizo patients with metastatic colorectal cancerAllan Ramos-Esquivel, Ricardo Chinchilla-Monge, Jad Abbas, et al.
Journal of Nephropathology|October 5, 2017
Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled studyViviana Navarro-Rodríguez, Alvaro Herrera-Munoz, Adrián Castro, et al.
Journal of Gastrointestinal Cancer|January 3, 2014
Prognosis impact of the lymph node ratio in patients with colon adenocarcinoma: a single-centre experienceAllan Ramos-Esquivel, Melissa Juárez, Ileana González, et al.
Pageof 4